ELMD Electromed Inc

Price (delayed)

$12.82

Market cap

$109.86M

P/E Ratio

47.48

Dividend/share

N/A

EPS

$0.27

Enterprise value

$98.88M

Electromed manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVestĀ® Airway Clearance System, to patients with compromised pulmonary function. The Company is headquartered in New Prague, ...

Highlights
ELMD's revenue is up by 17% year-on-year and by 6% since the previous quarter
The gross profit has grown by 15% YoY and by 6% from the previous quarter
ELMD's P/E is 83% above its 5-year quarterly average of 26.0 and 47% above its last 4 quarters average of 32.4
Electromed's EPS has decreased by 39% YoY and by 3.6% from the previous quarter

Key stats

What are the main financial stats of ELMD
Market
Shares outstanding
8.57M
Market cap
$109.86M
Enterprise value
$98.88M
Valuations
Price to earnings (P/E)
47.48
Price to book (P/B)
3.32
Price to sales (P/S)
2.91
EV/EBIT
32.51
EV/EBITDA
28.31
EV/Sales
2.62
Earnings
Revenue
$37.75M
EBIT
$3.04M
EBITDA
$3.49M
Free cash flow
$1.18M
Per share
EPS
$0.27
Free cash flow per share
$0.14
Book value per share
$3.86
Revenue per share
$4.41
TBVPS
$4.36
Balance sheet
Total assets
$37.9M
Total liabilities
$4.86M
Debt
$0
Equity
$33.04M
Working capital
$27.62M
Liquidity
Debt to equity
0
Current ratio
6.74
Quick ratio
6.1
Net debt/EBITDA
-3.14
Margins
EBITDA margin
9.3%
Gross margin
76.4%
Net margin
6%
Operating margin
8%
Efficiency
Return on assets
6.1%
Return on equity
6.9%
Return on invested capital
15%
Return on capital employed
9.2%
Return on sales
8.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELMD stock price

How has the Electromed stock price performed over time
Intraday
1.18%
1 week
0.47%
1 month
6.66%
1 year
24.59%
YTD
-1.38%
QTD
-1.38%

Financial performance

How have Electromed's revenue and profit performed over time
Revenue
$37.75M
Gross profit
$28.86M
Operating income
$3.02M
Net income
$2.27M
Gross margin
76.4%
Net margin
6%
Electromed's net margin has decreased by 47% YoY and by 9% from the previous quarter
Electromed's operating margin has decreased by 42% YoY and by 9% QoQ
The net income has declined by 38% year-on-year and by 4.1% since the previous quarter
ELMD's operating income is down by 32% year-on-year and by 4% since the previous quarter

Growth

What is Electromed's growth rate over time

Valuation

What is Electromed stock price valuation
P/E
47.48
P/B
3.32
P/S
2.91
EV/EBIT
32.51
EV/EBITDA
28.31
EV/Sales
2.62
ELMD's P/E is 83% above its 5-year quarterly average of 26.0 and 47% above its last 4 quarters average of 32.4
Electromed's EPS has decreased by 39% YoY and by 3.6% from the previous quarter
The price to book (P/B) is 33% higher than the 5-year quarterly average of 2.5 and 19% higher than the last 4 quarters average of 2.8
The equity rose by 7% year-on-year
The stock's price to sales (P/S) is 39% more than its 5-year quarterly average of 2.1 and 12% more than its last 4 quarters average of 2.6
ELMD's revenue is up by 17% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Electromed business performance
The company's return on assets fell by 45% YoY and by 6% QoQ
The ROE has contracted by 44% YoY and by 7% from the previous quarter
Electromed's ROS has decreased by 43% YoY and by 9% from the previous quarter
The ROIC has contracted by 37% YoY and by 7% from the previous quarter

Dividends

What is ELMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELMD.

Financial health

How did Electromed financials performed over time
Electromed's total liabilities has increased by 37% YoY and by 3.5% QoQ
The current ratio has declined by 19% year-on-year
Electromed's debt is 100% less than its equity
The equity rose by 7% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.